ArticleWorld journal of psychiatry2026
Meta-analysis on the efficacy of liver-soothing formulas for perimenopausal anxiety and depression.
Article in World journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerimenopausal women are prone to anxiety and depression due to fluctuating hormone levels, which significantly impair their quality of life. The current treatments have certain limitations. In traditional Chinese medicine, liver-soothing formulas are commonly prescribed for mood-related disorders, but their overall efficacy in perimenopausal anxiety and depression remains uncertain and requires verification through meta-analysis.
aimTo provide evidence-based support for clinical decision-making and research, a meta-analysis was conducted to evaluate the effectiveness of liver-soothing formulas in treating perimenopausal anxiety and depression.
methodsRelevant studies published up to April 2025 were retrieved from ClinicalTrials.gov, PubMed, Web of Science, EMBASE, and the Cochrane Library. Eligible studies were screened according to predefined inclusion and exclusion criteria. Data were extracted and analyzed using the Stata 12.0 software.
resultsAfter searching and screening, 12 articles involving 1798 patients (922 in the treatment group and 876 in the control group) were included in the analysis. Meta-analysis showed that the standardized scores for anxiety [standardized mean difference (SMD) = -0.71, 95% confidence interval (95%CI): -1.06 to -0.36] and depression (SMD = -0.67, 95%CI: -1.06 to -0.27) of the treatment group were lower than those of the control group. Subgroup analysis results revealed that for anxiety, liver-soothing formulas used alone (SMD = -0.34, 95%CI: -0.50 to -0.18) or in combination (SMD = -0.88, 95%CI: -1.43 to -0.34) both significantly reduced scores compared with the control group. For depression, monotherapy of liver-soothing formulas showed no significant statistical difference between the treatment and control groups (SMD = -0.47, 95%CI: -1.11 to 0.17), whereas combination therapy produced significantly lower standardized scale scores in the treatment group than in the control group, with a statistically significant difference (SMD = -0.83, 95%CI: -1.39 to -0.28). Regarding Greene scores, no statistically significant difference was observed with monotherapy (SMD = 0.87, 95%CI: -0.32 to 2.06), whereas combination therapy had significantly lower Greene scores (SMD = -0.24, 95%CI: -0.44 to -0.04). No statistically significant difference was found between the groups in the occurrence of adverse reactions (odds ratio = 0.90, 95%CI: 0.57-1.43). However, liver-soothing formulas did not affect estrogen levels in perimenopausal women.
conclusionCompared with placebo, conventional Western medicine, or other interventions, the monotherapy of liver-soothing formulas demonstrates superior efficacy in treating perimenopausal anxiety. When used as an adjuvant, they exert a synergistic effect in alleviating negative emotions and improving overall perimenopausal symptoms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.